Wełnicki, Marcin. 2025. “Why We Choose Fenofibrate? Fenofibrate in Long-Term Therapy – Larger Packages, Greater Benefits for Patients With Atherogenic Dyslipidemia”. Medycyna Faktow (J EBM) 18 (2(67), 290-92. https://doi.org/10.24292/01.MF.0225.18.